Reincarnated medicines: using out-dated drugs for novel indications
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reincarnated medicines: using out-dated drugs for novel indications
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 37, Issue 33, Pages 2571-2576
Publisher
Oxford University Press (OUP)
Online
2016-03-09
DOI
10.1093/eurheartj/ehw051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is the panic about beta-blockers in perioperative care justified?
- (2014) T. F. Luscher et al. EUROPEAN HEART JOURNAL
- Anti-inflammatory therapies for cardiovascular disease
- (2014) P. M. Ridker et al. EUROPEAN HEART JOURNAL
- New antiviral agents for the treatment of hepatitis C: ABT-450
- (2014) Andres F Carrion et al. EXPERT OPINION ON PHARMACOTHERAPY
- Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
- (2013) Brendan M. Everett et al. AMERICAN HEART JOURNAL
- Cardiovascular disease in Europe: epidemiological update
- (2013) Melanie Nichols et al. EUROPEAN HEART JOURNAL
- The bumpy road to evidence: why many research findings are lost in translation
- (2013) T. F. Luscher EUROPEAN HEART JOURNAL
- 2013 ESC guidelines on the management of stable coronary artery disease
- (2013) EUROPEAN HEART JOURNAL
- Effect of Shock Wave–Facilitated Intracoronary Cell Therapy on LVEF in Patients With Chronic Heart Failure
- (2013) Birgit Assmus et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Perioperative β-Blockade With Mortality and Cardiovascular Morbidity Following Major Noncardiac Surgery
- (2013) Martin J. London et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Revising common beliefs in the management of stable CAD
- (2013) Roberto Ferrari Nature Reviews Cardiology
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
- (2012) Sripal Bangalore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- (2012) D. Caldeira et al. BMJ-British Medical Journal
- Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity
- (2012) Jonathan L. Marks et al. Therapeutic Advances in Musculoskeletal Disease
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
- (2011) R. Huang et al. Science Translational Medicine
- n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
- (2010) Daan Kromhout et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Complications of Rheumatoid Arthritis: Assessment, Prevention, and Treatment
- (2010) Mariana J. Kaplan RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started